Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Tariq Zuheir Kewan, MD, Mahmoud Husni Hajyousef, MD, Associate Professor, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5185.

https://doi.org/10.1182/blood.V130.Suppl_1.5185.5185

Published: 2017

Journal Articles

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Anamarija M. Perry, MD, Diebold Jacques, MD, Bharat N. Nathwani, MD, Kenneth Angus Maclennan, MD, H Konrad Müller-Hermelink, Eugene Boilesen, Martin Bast, BS, James O. Armitage, MD, Dennis D. Weisenburger, MD

Blood (2015) 126 (23): 1484.

https://doi.org/10.1182/blood.V126.23.1484.1484

Published: 2015

Journal Articles

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Reiji Fukano, MD PhD, Shosuke Sunami, MD PhD, Masahiro Sekimizu, MDPhD, Tetsuya Takimoto, Tetsuya Mori, MDPhD, Tetsuo Mitsui, MD PhD, Takeshi Mori, MD, PhD, Akiko Moriya Saito, MD PhD, Tomoyuki Watanabe, Koichi Ohshima, Junichiro Fujimoto, MD PhD, Atsuko Nakazawa, MD PhD, Nobutaka Kiyokawa, MD PhD, Ryoji Kobayashi, MD PhD, Keizo Horibe, MD PhD, Masahito Tsurusawa, MD PhD

Blood (2014) 124 (21): 1728.

https://doi.org/10.1182/blood.V124.21.1728.1728

Published: 2014

Journal Articles

A Dual Proto-Oncogenic and Tumor Suppressive Role of LRF/POKEMON In Hemopoietic Malignancies through Control of Cell Fate Decision

Pier Paolo Pandolfi, MD, PhD

Blood (2010) 116 (21): SCI-14.

https://doi.org/10.1182/blood.V116.21.SCI-14.SCI-14

Published: 2010

Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD

Blood (2008) 112 (11): 5260.

https://doi.org/10.1182/blood.V112.11.5260.5260

Published: 2008

Journal Articles

Treatment Outcome and Prognostic Factors in Patients with Precursor B and T Lymphoblastic Lymphoma

Myung Hee Chang, Seok Jin Kim, MD, PhD, Won Seog Kim, Chul Won Choi, MD, PhD, Cheolwon Suh, Sung Hyun Kim, MD, PhD, Deok-Hwan Yang, Jong-Ho Won, Soon Il Lee

Blood (2008) 112 (11): 3601.

https://doi.org/10.1182/blood.V112.11.3601.3601

Published: 2008

Journal Articles

Incidence and Outcome of T-Cell Lymphomas in Malaysia.

Kian Meng Chang, MBBS, FRCPA, Ngee Siang Lau, MRCP, Lee Ping Chew, MRCP, Sen Mui Tan, MRCP, S. Jameela, MRCPath, V. Puru, FRCPath

Blood (2006) 108 (11): 4684.

https://doi.org/10.1182/blood.V108.11.4684.4684

Published: 2006

Journal Articles

Primary Gastric T-Cell Lymphoma: Clinicopathologic Features and Treatment Outcome.

Yeon Hee Park, MD, Won Seog Kim, MD, Soo-Mee Bang, MD, Soon Il Lee, MD, Ji Eun Uhm, MD, Hye Jin Kang, MD, Im Il Na, MD, Baek-Yeol Ryoo, MD, Sung Hyun Yang, MD, Kihyun Kim, MD, Seung Sook Lee, MD, Young H. Ko, MD, Keunchil Park, MD

Blood (2005) 106 (11): 3355.

https://doi.org/10.1182/blood.V106.11.3355.3355

Published: 2005

Journal Articles

CALGB 59901: Results of a Phase II Study of 506U78 in CTCL and PTCL.

Myron S. Czuczman, MD, Pierluigi Porcu, MD, Jeff Johnson, Donna Niedzwiecki, George P. Canellos, MD, Bruce D. Cheson, MD

Blood (2004) 104 (11): 2486.

https://doi.org/10.1182/blood.V104.11.2486.2486

Published: 2004

Journal Articles

Runx1 Deficiency Predisposes Mice to T-Cell Lymphoblastic Lymphoma.

Mondira Kundu, MD, PhD, Sheila Compton, MS, Lisa Garrett, MS, Terryl Stacy, PhD, Mathew Starost, DVM, Michael Eckhaus, DVM, Nancy A. Speck, PhD, Pu Paul Liu, MD, PhD

Blood (2004) 104 (11): 3490.

https://doi.org/10.1182/blood.V104.11.3490.3490

Published: 2004

Journal Articles

Overexpression of BHLHB1 (OLIG 2) Causes Precursor T-Cell Lymphoblastic Lymphoma/Leukemia (pre-T LBL) in the Presence of LMO1 Overexpression.

Yingwei Lin, MD, PhD, Ramona Deveney, Peter D. Aplan, MD

Blood (2004) 104 (11): 343.

https://doi.org/10.1182/blood.V104.11.343.343

Published: 2004

Journal Articles

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus

Elizabeth Hyjek, Amy Chadburn, Yi Fang Liu, Ethel Cesarman, Daniel M. Knowles

Blood (2001) 97 (1): 270–276.

https://doi.org/10.1182/blood.V97.1.270

Published: 2001

Journal Articles

Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)

Robert Lowsky, John F. DeCoteau, Armin H. Reitmair, Ryo Ichinohasama, Wei-Feng Dong, Yi Xu, Tak W. Mak, Marshall E. Kadin, Mark D. Minden

Blood (1997) 89 (7): 2276–2282.

https://doi.org/10.1182/blood.V89.7.2276

Published: 1997

NARROW

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

A Dual Proto-Oncogenic and Tumor Suppressive Role of LRF/POKEMON In Hemopoietic Malignancies through Control of Cell Fate Decision

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Treatment Outcome and Prognostic Factors in Patients with Precursor B and T Lymphoblastic Lymphoma

Incidence and Outcome of T-Cell Lymphomas in Malaysia.

Primary Gastric T-Cell Lymphoma: Clinicopathologic Features and Treatment Outcome.

CALGB 59901: Results of a Phase II Study of 506U78 in CTCL and PTCL.

Runx1 Deficiency Predisposes Mice to T-Cell Lymphoblastic Lymphoma.

Overexpression of BHLHB1 (OLIG 2) Causes Precursor T-Cell Lymphoblastic Lymphoma/Leukemia (pre-T LBL) in the Presence of LMO1 Overexpression.

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus

Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only